The figure Merqurio invented. First misunderstood, then opposed, finally imitated.
Scientific information by phone, web and webcam. A Merqurio registered trademark.
The doctor stays updated when and how they want. Information must follow them.
Over a third of doctors browse DottNet between 8pm and 8am: hours when a face-to-face visit is unthinkable. The doctor manages their updating in their own time, between PC and mobile, when it is most convenient. Face-to-face information, on its own, no longer intercepts these moments.
The Informatore Remoto® — born at Merqurio in the 1990s — is the answer: a scientific rep who operates by phone and web, an alternative or support to the face-to-face visit, which makes it possible to eliminate unproductive expenses and to reach the doctor when they are available. Not a call centre: a pharma professional, with the same competences as the field rep.
Scientific information by phone, web and video call: remote information with branded content and call scripts adapted to the individual doctor's journey.
Facilitated access for the doctor via DottNet credentials, with a significant increase in video calls made.
Real-time tracking of the doctor's online activity in the campaign, to centre the relationship on their real interests.
Information on mature products, sales-force support, notices on product changes, lead generation and appointment acquisition, increased subscriptions to restricted areas.
Remote covers those the field network does not reach.
A remote call between one field visit and the next keeps the relationship alive.
Remote garrisons products that do not justify a dedicated field visit.
Remote reaches more doctors at a lower cost than field alone.
The Informatore Remoto® is not a service Merqurio bought or copied: it invented it. This means competence, process and technology built on thirty years of practice, not on a recent adaptation.
The proprietary database targets doctors and the integration with DottNet facilitates access. The figure is a pharma professional, trained and integrated into the pharmacovigilance process.
